天合光能（688599.SH）2024 年年报及 2025 年一季报点评 | 项目/年度 | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业收入（百万元） | 80,282 | 77,720 | 88,905 | 101,161 | | 增长率（%） | -29.2 | -3.2 | 14.4 | 13.8 | | 归属母公司股东净利润（百万元） | -3,443 | 998 | 1,956 | 2,905 | | 增长率（%） | -162.3 | 129.0 | 95.9 | 48.5 | | 每股收益（元） | -1.58 | 0.46 | 0.90 | 1.33 | | PE | / | 29 | 15 | 10 | | PB | 1.1 | 1.0 | 1.0 | 0.9 | ➢ 多业务齐头并进，打造综合能源整体解决方案服务商。储能：公司储能产品 销售遍及全球，累计出货超过 10GWh，参与多个国内外大项目。支架：24 年公 司支架实现出货 7.3GW，其中跟踪支架维持增长态势，在欧洲、拉美和中东等重 点区域出 ...

[Table_StockNameRptType] 中密控股（300470） 公司点评 24 年报+25Q1 点评：业绩符合预期，25Q1 归母净利同比+13.84% | [Table_Rank] 投资评级：买入（维持） | | | --- | --- | | 报告日期： | 2025-05-06 | | [Table_BaseData] 收盘价（元） | 36.07 | | 近 12 个月最高/最低（元） | 45.18/31.51 | | 总股本（百万股） | 208 | | 流通股本（百万股） | 197 | | 流通股比例（%） | 94.8% | | 总市值（亿元） | 75.09 | | 流通市值（亿元） | 71.25 | [公司价格与 Table_Chart] 沪深 300 指数走势比较 -30% -20% -10% 0% 10% 20% 30% 中密控股 沪深300 [分析师： Table_Author] 张帆 执业证书号：S0010522070003 邮箱： zhangfan@hazq.com 分析师： 陶俞佳 执业证书号：S0010524100004 邮箱：taoyujia@hazq.co ...

证券研究报告·公司点评报告·IT 服务Ⅱ 辰安科技（300523） ◼ 聚焦机器人+低空应用场景落地：针对机器人，公司子公司科大立安"空 地一体化"智能灭火平台推出四足灭火机器狗，以"环境实时检测"与 "复杂地形攻坚"为核心，突破室内火场救援瓶颈，实现"人机协同、 安全高效"的灭火新模式。针对低空经济，子公司科大立安"空地一体 化"智能灭火平台创新推出无人机高空火源动态检测与高压精准压制系 统，通过"智能侦察+集群压制"技术，为超高层建筑外立面火灾提供 高效、安全的解决方案。 2025 年 05 月 06 日 证券分析师 王紫敬 执业证书：S0600521080005 021-60199781 wangzj@dwzq.com.cn 2024 年年报和 2025 年一季报点评：25Q1 超 市场预期，聚焦产品 AI 化 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 2,257 | 1,401 | 2,029 | ...

业绩承压,资源整合优势提升长期竞争力 [Table_StockName] ——华润三九（000999）点评报告 [Table_ReportDate] [Table_Summary] 事件: 3 月 13 日，公司发布 2024 年年报。2024 年公司实现总营业收入 276.17 亿元（+11.63%）；归母净利润 33.68 亿元（+18.05%）。 4 月 29 日，公司发布 2025 年一季报。2025Q1，公司实现总营业收入 68.54 亿元（-6.04%）；归母净利润 12.70 亿元（-6.87%）。 投资要点: CHC：在去年流感高发高基数的情况下，今年一季度感冒品类终端的实 际动销情况相比较弱。公司感冒药，胃药，皮肤药保持平稳发展态势。 公司今年新上市一个 3.2 类新药 999 益气清肺颗粒，作为呼吸品类重 要补充，助力公司在呼吸感冒品类形成更有竞争壁垒的护城河。 处方药：公司不断提升处方药产品线学术价值和竞争力，并积极拥抱国 药业务的集采。公司一季度完成对天士力 28%的股权的收购，持续提升 行业整合优势。随着集采推进，昆药集团有望获取更多空白市场新增空 间。公司通过昆药渠道变革，三七产品 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved double-digit growth in both revenue and profit for 2024, with a notable increase in non-recurring net profit growth [2][3] - The company's revenue for 2024 reached 1.203 billion yuan, a year-on-year increase of 14.75%, while the net profit attributable to shareholders was 254 million yuan, up 15.95% year-on-year [2] - The first quarter of 2025 showed a slight decline in revenue and profit, indicating some pressure on performance [2][3] Financial Performance - In 2024, the company reported a gross margin of 41.88%, an increase of 0.56 percentage points year-on-year, with a total expense ratio of 11.81%, down 1.49 percentage points [4] - The blood products segment generated revenue of 1.072 billion yuan in 2024, a year-on-year increase of 8.80%, with a gross margin of 43.04% [5] - The company’s plasma collection volume increased by 8.7% in 2024, reaching 562 tons [5][8] Future Projections - Revenue projections for 2025, 2026, and 2027 are 1.347 billion yuan, 1.497 billion yuan, and 1.653 billion yuan, respectively, with year-on-year growth rates of 12.0%, 11.1%, and 10.4% [9][10] - The net profit attributable to shareholders is expected to be 299 million yuan, 345 million yuan, and 396 million yuan for 2025, 2026, and 2027, respectively, with growth rates of 18.0%, 15.3%, and 14.8% [9][10]

汽车｜ 汽车零部件 轮胎销量持续增长，全球布局再下一城 | 预测指标 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 主营收入(亿元) | 201.65 | 220.57 | 240.20 | 256.85 | 282.28 | | 净利润(亿元) | 13.90 | 17.52 | 20.21 | 22.86 | 25.23 | | 每股收益（元） | 0.95 | 1.20 | 1.38 | 1.56 | 1.72 | | 每股净资产（元） | 14.28 | 14.81 | 15.78 | 16.88 | 18.08 | | P/E | 14.99 | 11.89 | 10.31 | 9.11 | 8.26 | | P/B | 1.00 | 0.96 | 0.90 | 0.84 | 0.79 | 资料来源： iFinD ，财信证券 投资要点： 证券研究报告 公司点评 玲珑轮胎(601966.SH) 涨跌幅比较 % 1M 3M 12M 玲珑轮胎 -20.00 -21.33 -34.50 汽车 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative return of over 20% within the next six months [7][18]. Core Views - The company's net profit for Q1 2024 exceeded expectations, driven by the accelerated growth of its high-end brand "Wuji" [5][6]. - The company is projected to achieve a revenue of 16.82 billion yuan in 2024, representing a year-on-year growth of 28.74%, and a net profit of 1.12 billion yuan, reflecting a significant increase of 92.19% [6][5]. - The report highlights the strong performance of the "Wuji" brand, which saw a revenue increase of 111.43% in 2024, with domestic sales growing by 114% and international sales by 108% [3][5]. Financial Performance Summary - For the full year 2024, the company is expected to achieve a gross margin of 17.59%, a net profit margin of 6.67%, and a non-GAAP net profit margin of 6.51% [5][6]. - The report indicates a significant improvement in the company's cost management, with a decrease in the expense ratio to 7.28% [5][6]. - The company’s revenue for Q4 2024 was 4.60 billion yuan, a year-on-year increase of 24.35%, but the net profit decreased by 207.36% compared to the previous year [2][5]. Growth Drivers - The "Wuji" brand is positioned as a leading high-end motorcycle brand in China, with plans to deepen its market presence in Europe and expand into Latin America and Southeast Asia [3][5]. - The all-terrain vehicle (ATV) segment is also showing promise, with sales revenue reaching 403 million yuan in 2024, a year-on-year growth of 73.85% [4][5]. - The company has established a robust distribution network, with over 2,000 dealers across more than 90 countries, enhancing its market reach [4][5].

公司报告 | 年报点评报告 应流股份（603308） 证券研究报告 一季度利润符合预期，两机叶片开启陡峭成长曲线 2024 年全年：1）实现营收 25.13 亿元，同比+4.21%；实现归母净利润 2.86 亿元，同比-5.57%； 实现扣非归母净利润 2.77 亿元，同比-1.09%。2）全年毛利率 34.24%，同比-1.93pct；归母净 利润率 11.39%，同比-1.18pct；扣非归母净利润率 11.02%，同比-0.59pct。 2024Q4 单季度：1）实现营收 6.03 亿元，同比-0.31%，环比-6.14%；实现归母净利润 0.6 亿 元，同比-0.14%，环比-20.43%；实现扣非归母净利润 0.57 亿元，同比-31.45%，环比-20.96%。 2）Q4 单季度毛利率 35.35%，同比+1.37pct，环比+2.39pct；归母净利润率 9.88%，同比+0.02pct， 环比-1.77pct；扣非归母净利润率 9.37%，同比-4.26pct，环比-1.76pct。 两机业务：战略协议密集签约，开启陡峭成长曲线。两机业务在手订单和销售收入实现双双 增长，公司累计已开发完成"两 ...

公司报告 | 年报点评报告 陕鼓动力（601369） 证券研究报告 一季度业绩符合预期，各业务板块稳步前进，分红率持续提升 2024 年全年：1）实现营收 102.77 亿元，同比+1.32%；实现归母净利润 10.42 亿元，同比+2.09%； 实现扣非归母净利润 9.5 亿元，同比+2.04%。2）全年毛利率 22.51%，同比+1.02pct；归母净 利润率 10.14%，同比+0.08pct；扣非归母净利润率 9.24%，同比+0.07pct。3）期间费用率为 9.18%，同比+1.28pct，销售/管理/研发/财务费用率分别为 2.31%、5.34%、4.05%、-2.52%， 同比分别变动-0.31、-0.28、+1.32、+0.55pct。 2024Q4 单季度：1）实现营收 29.88 亿元，同比+3.97%，环比+30.73%；实现归母净利润 3.75 亿元，同比+27.6%，环比+80.73%；实现扣非归母净利润 3.28 亿元，同比+26.03%，环比+73.94%。 2）Q4 单季度毛利率 21.66%，同比+4.98pct，环比-0.06pct；归母净利润率 12.57%，同比+2. ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the benchmark index [5][7]. Core Insights - The company has shown resilience in its core aviation traffic management and urban traffic management businesses, with revenue from the aviation sector growing by 13.68% year-on-year and urban traffic management increasing by 33.47% [2]. - The company is actively investing in research and development, with R&D expenditures reaching 146 million yuan in 2024, a 13.21% increase from the previous year [3]. - The company is positioning itself as a leader in the low-altitude economy, launching a comprehensive solution centered around the "Tianmu" low-altitude flight service management platform and establishing a provincial-level low-altitude platform in Jiangsu [4]. Financial Performance Summary - In 2024, the company reported total revenue of 1.61 billion yuan, a decrease of 3.94% year-on-year, and a net profit of 129 million yuan, down 2.31% year-on-year [2]. - The first quarter of 2025 saw a significant decline in revenue to 109 million yuan, a drop of 55.53% year-on-year, with a net loss of 15 million yuan [2]. - Revenue projections for 2025-2027 are estimated at 1.85 billion, 2.11 billion, and 2.38 billion yuan respectively, with net profits expected to reach 165 million, 208 million, and 252 million yuan [5][9].